SCHEMBL23097553

SCHEMBL23097553

CCCCNc1nc(C#Cc2ccc(Cl)s2)nc2c1ncn2[C@@H]1C[C@](C)(C(=O)NC)[C@@H](O)[C@H]1O

nearest known ligand 0.78

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 16/20 0.78
▸ SLC6A2 P23975 4/20 0.71
▸ SLC6A3 Q01959 4/20 0.71
▸ ADRB3 P13945 1/20 0.71
▸ KCNH2 Q12809 2/20 0.61
▸ ADORA1 P30542 2/20 0.61
▸ ADORA2A P29274 1/20 0.61
▸ TMIGD3 P0DMS9 4/20 0.60
▸ ADRA2A P08913 1/20 0.60
▸ ADRA2B P18089 1/20 0.60
▸ SLC6A4 P31645 1/20 0.60
▸ CYP1A2 P05177 1/20 0.59
▸ CYP3A4 P08684 1/20 0.59
▸ CYP2D6 P10635 1/20 0.59
▸ CYP2C19 P33261 1/20 0.59
▸ OPRD1 P41143 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22359595 1.00 ADORA3 (0.78) ADORA3SLC6A2SLC6A3ADRB3KCNH2
SCHEMBL22359594 0.96 ADORA3 (0.77) ADORA3SLC6A2SLC6A3ADRB3KCNH2
SCHEMBL20122135 0.93 ADORA3 (0.76) ADORA3SLC6A2SLC6A3ADRB3KCNH2
SCHEMBL23097510 0.90 ADORA3 (0.75) ADORA3SLC6A2SLC6A3ADRB3KCNH2
SCHEMBL23097496 0.90 ADORA3 (0.75) ADORA3SLC6A2SLC6A3ADRB3KCNH2
SCHEMBL20122133 0.90 ADORA3 (0.75) ADORA3SLC6A2SLC6A3ADRB3KCNH2
SCHEMBL22359585 0.90 ADORA3 (0.78) ADORA3SLC6A2SLC6A3ADRB3KCNH2
SCHEMBL23097623 0.87 ADORA3 (1.00) ADORA3SLC6A2SLC6A3ADRB3KCNH2
SCHEMBL20122071 0.87 ADORA3 (1.00) ADORA3SLC6A2SLC6A3ADRB3KCNH2
SCHEMBL16774255 0.87 ADORA3 (1.00) ADORA3SLC6A2SLC6A3ADRB3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3074398-B1 A3 ADENOSINE RECEPTOR AGONISTS US HEALTH (US) 2021-03-17 — — EP disclosed
Send feedback